Latest Industry Insights
Industry Insight
Beyond Black-Box Models: Advances in Data-Driven ADMET Modeling
Discover how AI-powered ADMET modeling can enable the prediction of toxicity and pharmacokinetics with depth, transparency and scientific rigor.
Industry Insight
Are Plans To Phase Out Animal Testing Realistic?
Cell models are replacing animal testing in pharma. Explore expert tips on transitioning to more accurate, ethical and scalable alternatives.
Industry Insight
Advancing Drug Discovery With Functional Proteomics
Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.
Industry Insight
Molecular Glues Meet Precision Discovery To Advance Oncology Treatments
From theory to clinic, explore how molecular glue innovation is transforming targeted protein degradation for cancer and other diseases. Offering a new path to degrade targets once thought undruggable.
Industry Insight
Multiomics: A 360° View into Biology and Medicine
Explore how multiomics research combines genomics, proteomics, and transcriptomics to offer new insights in disease modeling and therapeutic advancements.
Industry Insight
Beyond the Scale: How Targeted Weight Loss Transforms Metabolic Health and Lowers Healthcare Costs
Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being. Explore the latest weight loss research and learn how even moderate weight loss can transform metabolic health.
Industry Insight
Advancing Small Molecule Analysis For PFAS, Drugs and Contamination Detection
Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.
Industry Insight
Building Agility, Compliance and Sustainability in Sample Storage
In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.
Industry Insight
Harnessing the Immune System To Combat Antimicrobial Resistance
Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.
Industry Insight
Anti-Infective Development Boosted by AI and Automation
Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.
Advertisement